International collaborative research has analyzed Ebola virus genomes from the 2013–2016 outbreak, uncovering the role of factors such as language and distance between cities.
Browsing: Emerging Disease
Environmental change, and a growing and more connected population will promote vector-borne disease risk further. In this opinion piece, the authors discuss the role of climate modeling in disease prediction and epidemiology.
Although understanding of Ebola virus pathogenesis has rapidly increased recently, many questions relating to the role of the vascular system remain unanswered. The authors here discuss how Ebola virus infection can cause endothelial dysfunction and coagulopathy.
Researchers have identified the southern states of the USA as most at risk of high burden from Zika virus.
Researchers have demonstrated that outbreaks of dengue virus have a local structure, and hope their findings on transmission patterns could lead to better targeted interventions.
A Phase I clinical trial has demonstrated two investigational Ebola vaccines generate a durable immune response 1 year after vaccination.
In this piece, author Jean-François Etard, summarizes his work on the Postebogui cohort and argues that patients declared free of Ebola virus disease should receive follow-up for at least 18 months after discharge from treatment centers.
Researchers have suggested Zika may have adverse effects on the cardiovascular system based on new data from a small case report; an association which has previously been unreported.
Researchers have analyzed the clinical characteristics of Zika infection in Canadian travelers returning from the Americas, discovering that severe complications might be more common than previously estimated.